143 related articles for article (PubMed ID: 22038668)
1. Leptomeningeal Carcinomatosis in Esophageal Cancer: Case Report and Review of Literature.
Aulakh AS; Buttar A; Piperdi B
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S84-8. PubMed ID: 22038668
[No Abstract] [Full Text] [Related]
2. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
3. A Fulminant Case of Leptomeningeal Carcinomatosis Secondary to Esophageal Adenocarcinoma.
Fresko BT; Selam MT; Tuzlali H; Batman B; Asoglu O
J Gastrointest Cancer; 2016 Mar; 47(1):111-3. PubMed ID: 25972065
[No Abstract] [Full Text] [Related]
4. Intraventricular chemotherapy for leptomeningeal carcinomatosis from lung cancer: a feasible and beneficial treatment option?
Christoph DC; Reckamp KL
J Thorac Oncol; 2013 May; 8(5):523-4. PubMed ID: 23584292
[No Abstract] [Full Text] [Related]
5. Syndrome of inappropriate antidiuretic hormone in a patient with leptomeningeal carcinomatosis.
Boursiquot R; Krol D; Hanif S; Rojas J; Jain M
J Med Case Rep; 2016 Mar; 10():73. PubMed ID: 27036107
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal carcinomatosis of gastric adenocarcinoma.
Bulut G; Erden A; Karaca B; Göker E
Turk J Gastroenterol; 2011; 22(2):195-8. PubMed ID: 21796558
[TBL] [Abstract][Full Text] [Related]
7. Promising Effects of Afatinib on Leptomeningeal Carcinomatosis Derived from Erlotinib-resistant Lung Adenocarcinoma.
Sekine A; Kato T; Iwasawa T; Baba T; Suido A; Sakuranaka H; Futaki M; Ogura T
Intern Med; 2016; 55(17):2457-61. PubMed ID: 27580550
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib.
Ariyasu R; Horiike A; Koyama J; Saiki M; Sonoda T; Kawashima Y; Takano N; Oguri T; Nishikawa S; Kitazono S; Yanagitani N; Ohyanagi F; Nishio M
Anticancer Drugs; 2017 Jun; 28(5):565-567. PubMed ID: 28225456
[TBL] [Abstract][Full Text] [Related]
9. An unexpected response to second line EGFR inhibitor in relapsing leptomeningeal carcinomatosis from lung adenocarcinoma raises questions on differential mechanisms of action of these agents.
Ghosn M; Assi T; El Rassy E; Moussa T; Kattan J
Bull Cancer; 2017 Apr; 104(4):385-387. PubMed ID: 28131317
[No Abstract] [Full Text] [Related]
10. Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
Cavanna L; Rocchi A; Gorgni S; Ambroggi M; Foroni RP; Ubbiali A; Civardi G
J Clin Oncol; 2011 May; 29(13):e367-8. PubMed ID: 21300922
[No Abstract] [Full Text] [Related]
11. [A case of lung adenocarcinoma with coexisting G719X and T790M EGFR mutations in which erlotinib was effective for the treatment of leptomeningeal carcinomatosis].
Katono K; Kasajima M; Ishihara M; Hayashi N; Nagashima Y; Igawa S; Masuda N
Gan To Kagaku Ryoho; 2013 Mar; 40(3):375-7. PubMed ID: 23507602
[TBL] [Abstract][Full Text] [Related]
12. Meningeal carcinomatosis from pulmonary adenocarcinoma.
Doctor AM; Sharma S; Maheshwari M
Indian J Cancer; 2008; 45(2):74-5. PubMed ID: 18626156
[No Abstract] [Full Text] [Related]
13. First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patient.
Hollebecque A; Levy A; Broutin S; Lemare F; Gazzah A; Desmaris R; Chenailler C; Elbaum M; Besse B; Paci A; Soria JC
Lung Cancer; 2013 Apr; 80(1):113-4. PubMed ID: 23352031
[No Abstract] [Full Text] [Related]
14. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
15. Fatal progression of the leptomeningeal carcinomatosis from primary rectal adenocarcinoma: A case report.
Lee TG; Hwang HJ
Asian J Surg; 2024 May; 47(5):2328-2330. PubMed ID: 38336490
[No Abstract] [Full Text] [Related]
16. Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
Jiao XD; Ding C; Zang YS; Yu G
BMC Cancer; 2018 Feb; 18(1):206. PubMed ID: 29463236
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic Meningitis.
Pappa E; Conforti R; Hoang-Xuan K; Alentorn A
Can J Neurol Sci; 2019 May; 46(3):358-359. PubMed ID: 30905325
[No Abstract] [Full Text] [Related]
18. [Treatment of leptomeningeal carcinomatosis from gastric cancer].
Okuda T; Kataoka K; Kato A
Gan To Kagaku Ryoho; 2009 Apr; 36(4):599-603. PubMed ID: 19381031
[TBL] [Abstract][Full Text] [Related]
19. Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.
Maur M; Omarini C; Piacentini F; Fontana A; Pettorelli E; Cascinu S
Am J Case Rep; 2017 Feb; 18():208-211. PubMed ID: 28242865
[TBL] [Abstract][Full Text] [Related]
20. [Brain Metastasis and Leptomeningeal Carcinomatosis after Surgery for Esophageal Cancer-A Case Report].
Kinugasa S; Kobayashi I; Horikawa M; Tatara T; Kawashima T; Monma H; Fujimoto M; Aihara H; Takase S
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1593-1595. PubMed ID: 33268734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
